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1. Introduction 
The maximum activities of fructose-l ,6diphospha- 
tase (FDPase) (EC 3.1.3.11) and mitochondrial gly- 
cerol-l-phosphate dehydrogenase (EC 1.1.2.1) have 
been measured in a wide variety of different muscles 
[I] and the distribution of these two enzymes fails to 
support the two previous hypotheses concerning the 
role of FDPase in muscle: the removal of glycerol-l- 
phosphate after exercise [2] and the control of the 
glycerol-l-phosphate cycle [3]. Therefore another role 
for FDPase was sought and to this end the maximum 
activities of phosphofructokinase (PFK) (EC 2.7.1.11) 
and FDPase were measured in a variety of muscles 
from different animals. Some of these activities are 
presented in this paper and a hypothesis is advanced 
which explains both the relationship between the ac- 
tivities of PFK and FDPase and the surprising distri- 
bution of FDPase in muscle tissue. The paper examines 
theoretically the problem of controlling the activity of 
an enzyme through the equilibrium-binding of a regu- 
latory molecule. It is proposed that FDPase is present 
in skeletal muscle to provide cycling between fructose- 
6-phosphate and fructose disphosphate (catalysed by 
PFK and FDPase) when the muscle is at rest, and this 
markedly increases the sensitivity of fructosed-phos- 
phate phosphorylation to changes in the concentration 
of AMP. 
2. Methods 
Animals were obtained from sources described pre- 
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viously [4] . Muscle tissue was extracted and PFK and 
FDPase activities were assayed as described previously 
[3] , except that the incubation buffer for the latter 
enzyme contained 4 mM creatine phosphate, 0.16 
mg/ml creatine phosphokinase and 1 mM Mn2+: these 
additions were made to reduce as much as possible the 
AMP inhibition of FDPase. The specifity of FDPase 
was tested by showing inhibition upon addition of 
AMP (1 mM) or fructose diphosphate (5 mM). In some 
insect flight muscles PFK was found to be very un- 
stable and therefore its maximum activity has been 
assessed as the sum of phosphorylase and hexokinase 
activities [l] . The enzyme activities reported in this 
paper are the means of at least two separate determi- 
nations (with two animals or two separate pools of 
muscle from a larger number of animals) with a varia- 
tion of less than 30% between individual determina- 
tions. 
3. Results 
On the basis of the maximal activities of PFK and 
FDPase, muscles can be divided into two groups: firstly 
those in which FDPase activity is very low (<0.05 
I_cmole/min/g fresh muscle); and secondly those in 
which the activity of FDPase varies between approxi- 
mately 2-10% of that of PFK (table 1). The highest 
activities of FDPase were obtained in two completely 
different types of muscle: aerobic muscles of some 
insects and the anaerobic pectoral muscles of some 
birds (e.g. pheasant) (table 1). However very low ac- 
tivities have been observed in some aerobic vertebrate 
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Table 1 
April 1970 
The activities of PFK and FDPase in various muscles from different animals. 
Animal Muscle 
Locust 
(Schistocerca gregaria) 
Cockroach 
(Periplaneta americana) 
Honey bee 
(Apis mellifera) 
Fresh fly 
(Sarcophaga barbata) 
Hawk moth 
(Laothoe populi) 
Frog 
(Rana temporan’a) 
Domestic flow1 
Pheasant 
(Phasianus colchicas) 
Flight 
Flight 
Flight 
Flight 
Flight 
Sartorius 
Pectoral 
Pectoral 
Enzyme activities 
(rmoles/min/g fresh muscle) 
PFK FDPase 
20.0* 0.9 
19.0 1.2 
33.0* 0.9 
74.0* 1.3 
9.0 < 0.05 
22.0 0.6 
105.7 2.5 
143.3 4.4 
FDPase as 
% of PFK 
4.5 
6.3 
2.1 
1.8 
_ 
2.9 
2.4 
3.1 
Cat Gastrocnemius 19.4 1.3 6.7 
* These values represent he sum of hexokinase and phosphorylase activities. 
muscles [2, 31 and in insect flight muscles that have 
low glycolytic capacities (table 1). 
4. Discussion 
In relation to the provision of energy for mechani- 
cal activity in skeletal muscle the activity of PFK (and 
therefore glycolysis) is regulated primarily by changes 
in the concentration of AMP [5,6], which through 
the adenylate kinase reaction magnifies changes in the 
concentration ratio ATP/ADP [7]. However the mag- 
nitude of the change in the latter is restricted because 
of the role that these nucleotides play in the provision 
of biological energy; the free energy of hydrolysis of 
ATP will vary as its concentration and large variations 
in this could interfere in the many reactions which are 
dependent upon a relatively constant supply of energy. 
For an enzyme whose activity is regulated by equi- 
librium-binding of a regulatory molecule, the sensiti- 
vity of this regulation can be analysed theoretically by 
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application of the allosteric model of Monod, Wyman 
and Changeux [8] . Although this model (and other 
similar models) increase the sensitivity of an enzyme 
to a change in concentration of the regulatory molecule 
above that obtained from a hyperbolic response, an 
increase in PFK activity from 10% to 90% requires at 
least a fourfold change in AMP concentration (tables 
2 and 3). From studies on intact muscle preparations 
a fourfold change in AMP concentration is the largest 
that has been reported [9]. However, in some muscle 
tissues in which the demand for energy is extremely 
high during contraction the increase in catalytic ac- 
tivity of PFK when the muscle is stimulated from rest 
may extend over a range greater than 10% to 90% of 
the maximum activity. For example in pheasant pec- 
toral muscle the maximum activity of PFK is 143 
pmole/g muscle/min and this represents the capacity 
of glycolysis to supply energy during flight; it can be 
estimated that the maximum glycolytic capacity during 
rest is approximately 2 pmole/g muscle/min. 
In such muscles the sensitivity of the control mecha- 
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Table 2 
The change in concentration of regulator molecule that is necessary to increase the fractional saturation of an allosteric enzyme 
from 0.1 to 0.9 according to the model of Monod, Wyman and Changeux [ 81. 
Allosteric 
constant 
Concentration of regulator 
providing fractional saturation of 
0.1 0.9 
Increase in concentration 
of regulator necessary to 
increase fractional 
saturation from 0.1 to 0.9 
1 0.18 8.0 44.4 
100 1.2 9.8 9.2 
500 2.0 11.5 5.7 
1,000 2.6 12.6 4.8 
10,000 5.0 19.6 3.9 
The enzyme is assumed to be tetrameric (n = 4), c = 0 and L 
has been used to calculate the fractional saturation i.e. Y = 
Table 3 
Theoretical effects of changes in the AMP concentration on the activities of PFK and FDPase and on the net rate of 
fructose&phosphate phosphorylation. 
Concn. 
AMP 
Fractional 
saturation of 
enzyme with AMP 
PFK activity 
(maximum = 100) 
FDPase activity 
(maximum = 10) 
Net F6P 
phosphorylation 
(i.e. PFK-FDPase) 
0.0 0.000 0.0 10.0 0.0 
2.0 0.050 5.0 9.5 0.0 
2.5 0.093 9.3 9.1 0.2 
3.0 0.150 15.0 8.5 6.5 
4.0 0.310 31.0 6.9 24.1 
6.0 0.600 60.0 4.0 56.0 
12.0 0.890 89.0 1.1 87.9 
20.0 0.950 95.0 0.5 94.5 
PFK activity is increased and that of FDPase is inhibited by AMP. It is assumed that the maximum activity of PFK is 100 units 
whereas that of FDPase is 10 units. Also at an AMP concentration approaching zero PFK is completely inhibited and FDPase is 
maximally active. The fractional saturation of the enzyme with AMP is calculated as in table 2; L = 103 and n = 4. It is assumed 
that there is strict proportional relationship between the binding of AMP and its activating or inhibitory effects on the two enzymes, 
nism can be markedly increased by the operation of a is an effective regulatory molecule is reduced and sen- 
cycle between fructose-6-phosphate and fructose di- sitivity is increased. As muscle FDPase is inhibited by 
phosphate catalysed by the simultaneous activities of AMP, an increase in the AMP concentration, which 
PFK and FDPase. A comparison of the sensitivities of increases the activity of PFK, will depress that of 
the control mechanisms involving PFK alone and PFK FDPase and ensure that, when energy is required for 
in combination with FDPase is shown in table 3. The muscular contraction, loss of energy and restriction of 
effect of cycling is to provide a threshold response of the rate of glycolysis at the stage of fructose-6-phos- 
the regulatory system to a change in AMP concentra- phate phosphorylation is reduced to a minimum 
tion, so that the concentration range over which AMP (table 3). 
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This hypothesis explains why the activity of FDPase 
is only 2- 10% of that of PFK in muscle; it also ex- 
plains the observed variation in distribution of FDPase 
in different muscles. For example, in both the aerobic 
insect flight muscles and the anaerobic pectoral mus- 
cles of birds the demand for energy varies tremendous- 
ly depending whether the muscle is working or at rest, 
so that the sensitivity of the glycolytic control mecha- 
nism would not be sufficient without cycling. How- 
ever, in vertebrate smooth muscle, in heart muscle 
and in postural muscles (e.g. semitendinosus of the 
rabbit), in which the activities of FDPase are very 
low there is almost always some mechanical activity 
and therefore a demand for glycolysis; and for this 
reason variation in the demand will not be excessive 
and cycling is not required. Similarly is not detec- 
table in those insect flight muscles in which the rate 
of glycolysis is low, i.e. where the muscle relies mainly 
on fat for energy production. 
It is possible to reduce glycolysis to very low rates 
in the isolated perfused rat heart by inhibition of PFK 
[lo] . This is brought about not by changes in the 
mechanical activity of the heart muscle, but by the 
oxidation of fatty acids (or ketone bodies) which in- 
crease the intracellular concentration of an inhibitor of 
PFK, citrate; the measured increase in the content of 
citrate in heart under these conditions is about five- 
fold [ 1 I] , whereas equilibrium-binding data (table 2) 
would predict a much larger change in citrate in order 
to produce substantial inhibition of PFK. Such a large 
change (approximately twenty-fold) is however pos- 
sible as citrate is produced in the mitochondria and 
PFK is extramitochondrial, so that the specific change 
in citrate in the latter compartment might be larger 
than the measured change in the whole tissue. It has 
been shown that the increase in citrate in the perfused 
heart on provision of ketone bodies requires approxi- 
mately ten minutes to reach a maximum [ 121 ; a large 
extramitochondrial accumulation could explain this 
delay. It should be reemphasised that equilibrium- 
binding can produce a satisfactory response in enzyme 
activity modulation provided the change in concen- 
tration of the regulator is sufficiently large; this is not 
possible with AMP because it is related to the ATP/ 
ADP concentration ratio of the cell and this must re- 
main relatively constant. 
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